Your browser doesn't support javascript.
loading
Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia.
Arime, Yosefu; Saitoh, Yoshito; Ishikawa, Mikiko; Kamiyoshihara, Chikako; Uchida, Yasuo; Fujii, Kazuki; Takao, Keizo; Akiyama, Kazufumi; Ohkawa, Noriaki.
Affiliation
  • Arime Y; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan. yarime@dokkyomed.ac.jp.
  • Saitoh Y; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Tochigi, Japan. yarime@dokkyomed.ac.jp.
  • Ishikawa M; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.
  • Kamiyoshihara C; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.
  • Uchida Y; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Fujii K; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.
  • Takao K; Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Akiyama K; Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Ohkawa N; Life Science Research Center, University of Toyama, Toyama, Japan.
Neuropsychopharmacology ; 49(4): 720-730, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38049583

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Limits: Animals / Humans Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Limits: Animals / Humans Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Reino Unido